01 / Vendor Profile
PROPHARMA GROUP, LLC Federal Contracts and Awards
UEI N6C8UMMHCB15 · CAGE 57X20
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $9.52M in net contract obligations to PROPHARMA GROUP, LLC across 46 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
PROPHARMA GROUP, LLC contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$770.9K
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $1.84M | 6 | 1 | — |
| FY 2021 | $2.84M | 7 | 1 | +54.0% |
| FY 2022 | $1.56M | 7 | 1 | −45.2% |
| FY 2023 | $1.36M | 8 | 2 | −12.8% |
| FY 2024 | $1.16M | 13 | 2 | −14.5% |
| FY 2025 | $770.9K | 5 | 1 | −33.5% |
04 / Federal Customers
Which federal agencies buy from PROPHARMA GROUP, LLC?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $9.50M | 43 | 99.8% | |
| 3600 | $21.8K | 1 | 0.2% | |
| 7524 | $0 | 2 | 0.0% |
05 / Contracting Offices
Which contracting offices buy from PROPHARMA GROUP, LLC?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N900 | NATIONAL INSTITUTES OF HEALTH | $9.49M | 42 | 99.6% | |
| 36C246 | VETERANS AFFAIRS, DEPARTMENT OF | $21.8K | 1 | 0.2% | |
| 75N920 | NATIONAL INSTITUTES OF HEALTH | $13.3K | 1 | 0.1% | |
| 75F401 | FOOD AND DRUG ADMINISTRATION | $0 | 2 | 0.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| R408 | SUPPORT- PROFESSIONAL: PROGRAM MANAGEMENT/SUPPORT | $9.44M | 41 | 1 | 99.1% |
| J065 | MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $49.9K | 1 | 1 | 0.5% |
| AN24 | HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; R&D ADMINISTRATIVE EXPENSES | $21.8K | 1 | 1 | 0.2% |
| R499 | SUPPORT- PROFESSIONAL: OTHER | $13.3K | 1 | 1 | 0.1% |
| Q701 | SPECIALIZED MEDICAL SUPPORT | $0 | 2 | 1 | 0.0% |
08 / Competition Pattern
How was PROPHARMA GROUP, LLC’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for PROPHARMA GROUP, LLC?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N90025F00002 | Aug 27, 2025 | $219.0K | NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH - CC | 541611 | R408 |
10 / Interpreting the Profile
How should you evaluate PROPHARMA GROUP, LLC as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.